Zevra Therapeutics (ZVRA) EBIT Margin Growth (1y) (2020 - 2026)
Zevra Therapeutics (ZVRA) EBIT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
796.95 Mn |
596.33 Mn |
34.30 Mn |
17,033.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
17,033.00 |
| Dec 31, 2025 |
15,560.00 |
| Sep 30, 2025 |
75,489.00 |
| Jun 30, 2025 |
26,631.00 |
| Mar 31, 2025 |
57,625.00 |
| Dec 31, 2024 |
-1,102.00 |
| Sep 30, 2024 |
-20,829.00 |
| Jun 30, 2024 |
-46,698.00 |
| Mar 31, 2024 |
-19,853.00 |
| Dec 31, 2023 |
30,736.00 |
| Sep 30, 2023 |
-52,643.00 |
| Jun 30, 2023 |
2,619.00 |
| Mar 31, 2023 |
-35,711.00 |
| Dec 31, 2022 |
-31,460.00 |
| Sep 30, 2022 |
10,880.00 |
| Jun 30, 2022 |
-14,867.00 |
| Mar 31, 2022 |
-10,433.00 |
| Dec 31, 2021 |
2,577.00 |
| Sep 30, 2021 |
-5,007.00 |
| Jun 30, 2021 |
1,113.00 |
